Celesio revenues, profits up
The company recorded group revenues of E15.9 billion for the period, including the acquired businesses of Danish pharmaceutical wholesalers K.V. Tjellesen and Max Jenne. EBITDA rose 8.6% to
Ultragenyx Pharmaceutical has received accelerated approval from the US Food and Drug Administration (FDA) for its gene therapy, Genglycos (pariglasgene brecaparvovec-opnr), to treat glycogen storage disease type Ia (GSDIa).